Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Cancer Diagnosis Program (CDP) — Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program (CDP) Biorepositories & Biospecimen Research Branch (BBRB)
Contact NExT
Show menu
Search this site
Last Updated: 09/01/17

Biospecimen Quality Assessment and Standards Development Workshop

The NCI BBRB and the National Institute of Standards and Technology (NIST) co-sponsored a workshop on October 21-22, 2010 to discuss the vital need for biospecimen quality assessment metrics and standards. Working groups composed of participants with expertise in basic, clinical, and regulatory science, held breakout discussions that centered on quality assessment for DNA, RNA, serum proteomics, and formalin-fixed and paraffin-embedded tissue.